Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

198.05 

-3.97 -2.0%

as of Mar 08 '21

52 Week Range:

159.24 236.51


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms, as well as related professional services. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 20.08
22.13
27.03
28.64
31.51
35.26
39.69
56.50
61.51
64.62
growth rate 10.2% 22.1% 6.0% 10.0% 11.9% 12.6% 42.4% 8.9% 5.1%
Earnings BIT 49.41
66.42
61.84
52.71
44.13
81.87
99.02
138.97
197.16
162.57
134.60
growth rate 34.4% -6.9% -14.8% -16.3% 85.5% 21.0% 40.4% 41.9% -17.5% -17.2%
Avg.PE 16.34
14.27
21.74
24.10
52.92
33.73
43.32
76.23
175.44
51.50
51.62
growth rate -12.7% 52.4% 10.9% 119.6% -36.3% 28.4% 76.0% 130.2% -70.7% 0.2%
ROA 9.96
13.27
10.46
8.71
5.06
7.70
9.48
6.24
1.87
6.16
growth rate 33.2% -21.2% -16.7% -41.9% 52.2% 23.1% -34.2% -70.0% 229.4%
ROE 11.47
15.02
11.61
9.45
5.41
8.27
10.17
7.39
2.34
7.65
growth rate 31.0% -22.7% -18.6% -42.8% 52.9% 23.0% -27.3% -68.3% 226.9%
ROIC 11.47
15.02
11.61
9.45
5.41
8.27
10.17
7.53
2.38
7.48
growth rate 31.0% -22.7% -18.6% -42.8% 52.9% 23.0% -26.0% -68.4% 214.3%
Cur. Ratio 8.07
8.88
11.18
14.67
15.21
11.85
14.03
4.11
3.72
3.55
growth rate 10.0% 25.9% 31.2% 3.7% -22.1% 18.4% -70.7% -9.5% -4.6%
Quick Ratio 5.76
6.94
9.45
12.73
13.43
10.21
12.37
2.47
2.34
2.01
growth rate 20.5% 36.2% 34.7% 5.5% -24.0% 21.2% -80.0% -5.3% -14.1%
Leverage 1.14
1.13
1.10
1.08
1.06
1.08
1.07
1.25
1.25
1.23
growth rate -0.9% -2.7% -1.8% -1.9% 1.9% -0.9% 16.8% 0.0% -1.6%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 55.10
47.65
53.42
49.67
39.05
57.85
57.18
219.60
201.51
206.64
124.09
growth rate -13.5% 12.1% -7.0% -21.4% 48.1% -1.2% 284.1% -8.2% 2.6% -40.0%
Acct.Payable 29.31
29.12
26.89
11.38
13.67
14.64
78.23
120.47
128.63
71.86
growth rate -0.7% -7.7% -57.7% 20.1% 7.1% 434.3% 54.0% 6.8% -44.1%
Cur.Assets 207.80
260.41
325.50
394.30
432.53
505.01
569.10
864.66
927.04
882.20
920.78
growth rate 25.3% 25.0% 21.1% 9.7% 16.8% 12.7% 51.9% 7.2% -4.8% 4.4%
Total Assets 312.20
361.11
428.51
499.64
541.10
626.83
704.69
1,496.95
1,585.39
1,692.38
1,763.69
growth rate 15.7% 18.7% 16.6% 8.3% 15.8% 12.4% 112.4% 5.9% 6.8% 4.2%
Cash 78.90
99.59
146.90
226.02
275.81
336.16
445.08
290.07
344.78
268.67
396.10
growth rate 26.2% 47.5% 53.9% 22.0% 21.9% 32.4% -34.8% 18.9% -22.1% 47.4%
Inventory 44.10
40.42
36.33
34.45
36.93
43.63
49.26
288.66
311.16
337.64
314.93
growth rate -8.3% -10.1% -5.2% 7.2% 18.1% 12.9% 485.9% 7.8% 8.5% -6.7%
Cur.Liabilities 25.80
29.31
29.12
26.89
28.73
42.62
40.54
210.29
249.29
248.47
195.49
growth rate 13.6% -0.7% -7.7% 6.9% 48.4% -4.9% 418.8% 18.5% -0.3% -21.3%
Liabilities 37.90
40.54
37.66
34.92
32.85
46.95
44.53
298.70
321.74
315.14
261.43
growth rate 7.0% -7.1% -7.3% -5.9% 42.9% -5.2% 570.7% 7.7% -2.1% -17.0%
LT Debt 0.00 0.00 0.00
growth rate
Equity 274.30
320.58
390.86
464.73
508.25
579.87
660.16
1,198.25
1,263.66
1,377.24
1,502.27
growth rate 16.9% 21.9% 18.9% 9.4% 14.1% 13.9% 81.5% 5.5% 9.0% 9.1%
Common Shares 14.00
14.00
15.00
15.00
16.00
16.00
17.00
21.00
22.00
22.00
2.11
growth rate 0.0% 7.1% 0.0% 6.7% 0.0% 6.3% 23.5% 4.8% 0.0% -90.4%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 22.30
15.82
19.16
18.42
16.60
12.98
23.36
74.48
92.72
97.31
growth rate -29.0% 21.1% -3.9% -9.8% -21.8% 79.9% 218.8% 24.5% 5.0%
Cash Dividends 0.00 0.00 0.00
growth rate
Cash From OA 33.10
64.49
66.27
65.73
66.34
64.20
89.94
154.42
160.22
101.92
growth rate 94.8% 2.8% -0.8% 0.9% -3.2% 40.1% 71.7% 3.8% -36.4%
FCF per Share 0.72
2.21
3.12
3.00
3.39
2.71
3.15
1.36
4.17
0.14
growth rate 206.9% 41.2% -3.9% 13.0% -20.1% 16.2% -56.8% 206.6% -96.6%
Sale Purchase of Stock -2.15
17.06
17.43
19.48
17.20
19.71
34.71
8.02
-10.91
growth rate 100.0% 2.1% 11.8% -11.7% 14.6% 76.1% -76.9% -100.0%
FCF 10.00
49.00
46.00
46.00
43.00
41.00
65.00
75.00
59.00
-4.00
growth rate 390.0% -6.1% 0.0% -6.5% -4.7% 58.5% 15.4% -21.3% -100.0%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 283.00
302.20
316.87
313.72
307.36
339.67
379.37
1,292.61
1,400.04
1,266.21
1,271.00
growth rate 6.8% 4.9% -1.0% -2.0% 10.5% 11.7% 240.7% 8.3% -9.6% 0.4%
Op.Income 47.70
44.67
41.28
40.42
44.13
81.87
99.02
138.97
197.16
162.57
134.60
growth rate -6.4% -7.6% -2.1% 9.2% 85.5% 21.0% 40.4% 41.9% -17.5% -17.2%
IBT 47.80
66.42
61.84
52.71
39.79
69.70
85.16
51.28
22.37
114.71
97.49
growth rate 39.0% -6.9% -14.8% -24.5% 75.2% 22.2% -39.8% -56.4% 412.7% -15.0%
Net Income 29.90
44.67
41.28
40.42
26.34
44.99
63.08
68.64
28.79
101.04
86.87
growth rate 49.4% -7.6% -2.1% -34.8% 70.8% 40.2% 8.8% -58.1% 250.9% -14.0%
EPS 2.16
3.15
2.80
2.65
1.68
2.73
3.66
3.29
1.33
4.69
growth rate 45.8% -11.1% -5.4% -36.6% 62.5% 34.1% -10.1% -59.6% 252.6%
Gross Profit 129.00
142.35
156.51
154.73
151.40
180.80
201.40
492.40
570.03
488.16
461.50
growth rate 10.4% 9.9% -1.1% -2.2% 19.4% 11.4% 144.5% 15.8% -14.4% -5.5%
R&D 4.70
8.59
10.63
12.41
18.33
15.71
12.96
51.25
52.87
48.61
42.95
growth rate 82.7% 23.8% 16.7% 47.8% -14.3% -17.6% 295.6% 3.2% -8.1% -11.7%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 56.18
38.36
28.76
32.94
34.53
growth rate -31.7% -25.0% 14.5% 4.8%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 202.22
202.07
201.77
168.52
124.09
growth rate -0.1% -0.2% -16.5% -26.4%
Acct.Payable 246.41
86.35
101.13
81.03
71.86
growth rate -65.0% 17.1% -19.9% -11.3%
Cur.Assets 882.20
1,002.18
1,036.71
900.14
920.78
growth rate 13.6% 3.5% -13.2% 2.3%
Total Assets 1,692.38
1,816.98
1,859.06
1,729.54
1,763.69
growth rate 7.4% 2.3% -7.0% 2.0%
Cash 268.67
419.56
446.13
350.99
396.10
growth rate 56.2% 6.3% -21.3% 12.9%
Inventory 337.64
311.60
322.77
321.96
314.93
growth rate -7.7% 3.6% -0.3% -2.2%
Cur.Liabilities 248.47
357.30
359.15
185.36
195.49
growth rate 43.8% 0.5% -48.4% 5.5%
Liabilities 297.84
441.09
447.27
277.32
261.43
growth rate 48.1% 1.4% -38.0% -5.7%
LT Debt 0.60
growth rate
Equity 1,377.24
1,375.89
1,411.80
1,452.22
1,502.27
growth rate -0.1% 2.6% 2.9% 3.5%
Common Shares 20.74
2.08
2.09
2.10
2.11
growth rate -90.0% 0.5% 0.1% 0.4%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 24.06
25.46
13.05
23.85
growth rate 5.8% -48.7% 82.7%
Cash Dividends
growth rate
Cash From OA 48.86
39.52
29.22
75.49
growth rate -19.1% -26.1% 158.3%
Sale Purchase of Stock -15.15
0.56
6.24
1.79
growth rate 100.0% 1,014.1% -71.4%
FCF 24.81
14.06
16.17
51.64
growth rate -43.3% 15.0% 219.4%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 315.52
328.61
303.38
318.57
320.45
growth rate 4.2% -7.7% 5.0% 0.6%
Op.Income 17.82
38.36
28.76
32.94
34.53
growth rate 115.3% -25.0% 14.5% 4.8%
IBT 20.92
20.38
20.84
26.17
30.11
growth rate -2.6% 2.2% 25.6% 15.1%
Net Income 20.64
16.83
18.91
24.99
26.14
growth rate -18.4% 12.3% 32.2% 4.6%
EPS
growth rate
Gross Profit 114.14
121.42
106.28
113.92
119.87
growth rate 6.4% -12.5% 7.2% 5.2%
R&D 12.59
10.75
10.28
10.13
11.80
growth rate -14.6% -4.4% -1.5% 16.5%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (43.79)

YOY Growth Grade:

D (34.99)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 50.25 49.27 25.74
EPS / Growth 33.7% 4.02 16.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 16.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 16.0% 16.2% 16.2%
Future PE 25.74 36.11 36.11
Future EPS 17.73 18.00 18.00
Value Price
MOS %
112.81
-43.0%
160.62
-18.9%
160.62
-18.9%
MOS Price 56.41 80.31 80.31
IRT 13.83 13.74 13.74

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.